Anonymous
Guest
Anonymous
Guest
http://www.reuters.com/article/2011...edType=RSS&feedName=rbssHealthcareNews&rpc=43
We missed target again. Stock dropping like a rock today. Four or five straight qtrs of decline. This is one poorly ran company. The turnover costs to this company is unreal. That is part of the bottom line in our TO costs. Dumb decision to stop once a month Actonel. Dumb decision to stop 400 Asacol. When the Generic 400 comes out, 800 will suffer. Anyway, the proof is in the data!
We missed target again. Stock dropping like a rock today. Four or five straight qtrs of decline. This is one poorly ran company. The turnover costs to this company is unreal. That is part of the bottom line in our TO costs. Dumb decision to stop once a month Actonel. Dumb decision to stop 400 Asacol. When the Generic 400 comes out, 800 will suffer. Anyway, the proof is in the data!